StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $6.05 | $5.55 | -8.26% | 0.0M |
| 05-19 | $6.25 | $5.77 | -7.68% | 0.0M |
| 05-20 | $5.59 | $5.68 | +1.61% | 0.0M |
| 05-21 | $6.05 | $5.81 | -3.97% | 0.0M |
| 05-22 | $6.25 | $6.10 | -2.40% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
No sell-side coverage available for NXPL yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $2.88M | $11.71M | $9.08M | $6.45M |
Operating Income | $-1.24M | $-7.20M | $-4.53M | $-2.37M |
Net Income | $-1.19M | $-9.16M | $-8.22M | $-1.66M |
EPS (Diluted) | $-0.08 | $-0.96 | $-0.88 | $-0.27 |
Total Assets | $27.71M | $28.64M | $20.54M | $25.09M |
Total Liabilities | $3.09M | $2.87M | $2.34M | $2.39M |
Cash & Equivalents | $16.72M | $18.89M | $12.47M | $20.47M |
Free Cash Flow OCF − CapEx | $-2.14M | $-4.32M | $-3.20M | $-2.28M |
Shares Outstanding | 14.44M | 14.40M | 9.65M | 9.29M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.